Back to the future: A new look at 'old' vitamin D

Journal of Endocrinology

Volumn 198, Issue 2, 2008, Pages 261-269

  Chun, Rene F ^a   Adams, John S ^a,b   Hewison, Martin ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; ALBUMIN; BAG 1 PROTEIN; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; CHAPERONE; CUBILIN; DOUBLE STRANDED DNA; ESTRADIOL; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HEAT SHOCK COGNATE PROTEIN 70; IMMUNOPHILIN; MEGALIN; SECOSTEROID; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; BINDING KINETICS; ENZYME KINETICS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; HYPOPHOSPHATEMIC RICKETS; IMMUNOREGULATION; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; MACROPHAGE; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW; SIGNAL PROCESSING; TARGET CELL; TRANSCRIPTION REGULATION; VITAMIN D RESPONSIVE ELEMENT;

ANIMALS; HUMANS; IMMUNITY, INNATE; MACROPHAGES; SIGNAL TRANSDUCTION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 51349133126     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0170     Document Type: Review

References (74)

1. Adams JS & Hewison M 2008 Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nature Clinical Practice. Endocrinology and Metabolism 4 80-90.
2. Adams JS, Chen H, Chun RF, Nguyen L, Wu S, Ren SY, Barsony J & Gacad MA 2003 Novel regulators of vitamin D action and metabolism: lessons learned at the Los Angeles zoo. Journal of Cellular Biochemistry 88 308-314.
3. Adams JS, Chen H, Chun R, Gacad MA, Encinas C, Ren S, Nguyen L, Wu S, Hewison M & Barsony J 2004 Response element binding proteins and intracellular vitamin D binding proteins: novel regulators of vitamin D trafficking, action and metabolism. Journal of Steroid Biochemistry and Molecular Biology 89-90 461-465.
4. Arbelle JE, Chen H, Gaead MA, Allegretto EA, Pike JW & Adams JS 1996 Inhibition of vitamin D receptor-retinoid X receptor-vitanim D response element complex formation by nuclear extracts of vitamin D-resistant New World primate cells. Endocrinology 137 786-789.
5. Arnaud J & Constans J 1993 Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Human Genetics 92 183-188.
6. Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, O'Loughlin PD & Morris HA 2007 Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone 40 1517-1528.
7. Bikle DD, Siiteri PK, Ryzen E & Haddad JG 1985 Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. Journal of Clinical Endocrinology and Metabolism 61 969-975.
8. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E & Haddad JG 1986 Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. Journal of Clinical Endocrinology and Metabolism 63 954-959.
9. Brandon DD, Markwick AJ, Chrousos GP & Loriaux DL 1989 Glucocorticoid resistance in humans and nonhuman primates. Cancer Research 49 2203s-2213s.
10. Carosa E, Fanelli A, Ulisse S, Di Lauro R, Rall JE & Jannini EA 1998 Ciona intestinalis nuclear receptor 1: a member of steroid/thyroid hormone receptor family. PNAS 95 11152-11157.
11. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S & Meunier PJ 1997 Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International 7 439-443.
12. Chen H, Arbelle JE, Gacad MA, Allegretto EA & Adams JS 1997 Vitamin D and gonadal steroid-resistant New World primate cells express an intracellular protein which competes with the estrogen receptor for binding to the estrogen response element. Journal of Clinical Investigation 99 669-675.
13. Chen H, Hu B, Gacad MA & Adams JS 1998 Cloning and expression of a novel dominant-negative-acting estrogen response element-binding protein in the heterogeneous nuclear ribonucleoprotein family. Journal of Biological Chemistry 273 31352-31357.
14. Chen H, Hu B, Allegretto EA & Adams JS 2000 The vitamin D response element-binding protein. A novel dominant-negative regulator of vitamin D-directed transactivation. Journal of Biological Chemistry 275 35557-35564.
15. Chen H, Hewison M, Hu B & Adams JS 2003 Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. PNAS 100 6109-6114.
16. Chen H, Hewison M & Adams JS 2006 Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitanim D resistance: a novel response element-binding protein. Journal of Biological Chemistry 281 39114-39120.
17. Chen H, Hewison M & Adams JS 2008 Control of estradiol-directed gene transactivation by an intracellular estrogen-binding protein and an estrogen response element-binding protein. Molecular Endocrinology 22 559-569.
18. Chrousos GP, Loriaux DL, Tomita M, Brandon DD, Renquist D, Albertson B & Lipsett MB 1986 The new world primates as animal models of glucocorticoid resistance. Advances in Experimental Medicine and Biology 196 129-144.
19. Chun R, Gacad MA, Hewison M & Adams JS 2005 Adenosine 5′-triphosphate-dependent vitamin D sterol binding to heat shock protein-70 chaperones. Endocrinology 146 5540-5544.
20. Chun RF, Gacad M, Nguyen L, Hewison M & Adams JS 2007 Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3. Journal of Molecular Endocrinology 39 81-89.
21. Constans J, Hazout S, Garruto RM, Gajdusek DC & Spees EK 1985 Population distribution of the human vitamin D binding protein: anthropological considerations. American Journal of Physical Anthropology 68 107-122.
22. Dreyfuss G, Hentze M & Lamond AI 1996 From transcript to protein. Cell 85 963-972.
23. van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, Pols HA & van Leeuwen JP 2006 Evidence for auto/paracrine actions of vitamin D in bone: 1α-hydroxylase expression and activity in human bone cells. FASEB Journal 20 2417-2419.
24. Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD & Hewison M 2006 Effects of 25-hydroxyvitanim D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biology of Reproduction 75 816-822.
25. Fasano M, Fanali G, Leboffe L & Ascenzi P 2007 Herne binding to albuminoid proteins is the result of recent evolution. IUBMB Life 59 436-440.
26. Fujiki R, Kim MS, Sasaki Y, Yoshimura K, Kitagawa H & Kato S 2005 Ligand-induced transrepression by VDR through association Of WSTF with acetylated hustones. EMBO Journal 24 3881-3894.
27. Fuller PJ, Srrmh BJ & Rogerson FM 2004 Cortisol resistance in the New World revisited. Trends in Endocrinology and Metabolism 15 296-299.
28. Gacad MA & Adams JS 1991 Endogenous blockade of 1,25-dihydroxyvitamin D-receptor binding in New World primate cells. Journal of Clinical Investigation 87 996-1001.
29. Gacad MA & Adams JS 1992 Specificity of steroid binding in New World primate B95-8 cells with a vitamin D-resistant phenotype. Endocrinology 131 2581-2587.
30. Gacad MA & Adams JS 1998 Proteins in the heat shock-70 family specifically bind 25-hydroxyvitamin D3 and 17beta-estradiol. Journal of Clinical Endocrinology and Metabolism 83 1264-1267.
31. Gacad MA, Chen H, Arbelle JE, LeBon T & Adams JS 1997 Functional characterization and purification of an intracellular vitamin D-binding protein in vitarnin D-resistant new world primate cells. Amino acid sequence homology with proteins in the hsp-70 family. Journal of Biological Chemistry 272 8433-8440.
32. Gao C, Goo H, Mi Z, Wai PY & Koo PC 2003 Transcriptional regulatory functions of heterogeneous nuclear ribonucleoprotein-U and -A/B in endotoxin-mediated macrophage expression of osteopontin. Journal of Immunology 175 523-530.
33. Gibbs PE, Witke WF & Dugaiczyk A 1998 The molecular clock runs at different rates among closely related members of a gene family. Journal of Molecular Evolution 46 552-561.
34. Gombart AF, Borregaard N & Koeffler HP 2005 Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB Journal 19 1067-1077.
35. Gomme PT & Bertolini J 2004 Therapeutic potential of vitamin D-binding protein. Trends in Biotechnology 22 340-345.
36. Hewison M, Rut AR, Kristjansson K, Walker RE, Dillon MJ, Hughes MR & O'Riordan JL 1993 Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clinical Endocrinology 39 663-670.
37. Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, Modlin RL & Adams JS 2007 Extra-renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in human health and disease. Journal of Steroid Biochemistry and Molecular Biology 103 316-321.
38. Hotick MF 1992 Evolutionary biology and pathology of vitainin D. Journal of Nutritional Science and Vitaminology Spec No 79-83.
39. Holick MF 2006 Vitarnin D: its role in cancer prevention and treatment. Progress in Biophysics and Molecular Biology 92 49-59.
40. Holick MF 2007 Vitamin D deficiency. New England Journal of Medicine 357 266-281.
41. Holick MF 2008 Vitamin D status: measurement, interpretation, and clinical application. Annals of Epidemiology (In press).
42. Johnson CS, Muindi JR, Hershberger PA & Trump DL 2006 The antitumor efficacy of calcitriol: preclinical studies. Anticancer Research 26 2543-2549.
43. Jurutka PW, Barrik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, Hsieh JC, Kaczmarska M, Haussler CA & Haussler MR 2007 Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. Journal of Bone and Mineral Research 22 V2-V10.
44. Kato S, Fujiki R & Kitagawa H 2004 Vitamin D receptor (VDR) promoter targeting through a novel chromatin remodeling complex. Journal of Steroid Biochemistry and Molecular Biology 89-90 173-178.
45. Lee WM & Galbraith RM 1992 The extracellular actin-scavenger system and actin toxicity. New England Journal of Medicine 326 1335-1341.
46. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wit K, Meinken C et al. 2006 Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 1770-1773.
47. Liu PT, Krutzik SR & Modlin RL 2007a Therapeutic implications of the TLR and VDR partnership Trends in Molecular Medicine 13 117-124.
48. Liu PT, Stenger S, Tang DH & Modlin RL 2007b Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. Journal of Immunology 179 2060-2063.
49. Makishima M, Lu TT Xie W, Whitfield GK, Dornoto H, Evans RM, Haussler MR & Mangelsdorf DJ 2002 Vitamin D receptor as an intestinal bile acid sensor. Science 296 1313-1316.
50. Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, Davidson RN, Sorensen OE, Kampmann B, Griffiths CJ et al. 2007 IFN-- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. Journal of Immunology 178 7190-7198.
51. Nagai J, Christensen EI, Morris SM, Willnow TE, Cooper JA & Nielsen R 2005 Mutually dependent localization of megalin and Dab2 in the renal proximal tubule. American Journal of Physiology-Renal Physiology 289 F569-F576.
52. Norman AW 2006 Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147 5542-5548.
53. Nykjaer A, Dragun D, Walther D, Vorum, H, Jacobsen C, Herz J, Melsen F, Christensen EI & Willnow TE 1999 An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96 507-515.
54. Nykjaer A, Fyfe JC, Kozyraki R, Leheste JR, Jacobsen C, Nielsen MS, Verroust PJ, Anunoff M, de la Chapelle A, Moestrup SK et al. 2001 Cubilin dysfunction causes abnormal metabolism ofthe steroid hormone 25(OH) vitamin D(3). PNAS 98 13895-13900,
55. Reschly EJ, Bainy AC, Mattos JJ, Hagey LR, Bahary N, Mada SR, Ou J, Venkataramanan R & Krasowski MD 2007 Functional evolution of the vitamin D and pregnane X receptors. BMC Evolutionary Biology 7 222
56. Rowling MJ, Kemmis CM, Taffany DA & Welsh J 2006 Megahn-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxy-cholecalciferol actions in human mammary cells. Journal of Nutrition 136 2754-2759.
57. Sabed PC, Varilly P, Fry B, Lohmueller J, Hostetter E, Cotsapas C, Xie X, Byrne EH, McCarroll SA, Gaudet R et al. 2007 Genome-wide detection and characterization of positive selection in human populations. Nature 449 913-918.
58. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, Liebhaber SA & Cooke NE 1999 Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. Journal of Clinical Investigation 103 239-251.
59. Schaubet, J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A et al. 2007 Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Journal of Clinical Investigation 117 803-811.
60. Speeckaert M, Huang G, Delanghe JR & Taes YE 2006 Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clinica Chimica Acta 372 33-42.
61. Speeckaert MM, Wehlou C, Vandewalle S, Taes YE, Robberecht E & Delanghe JR 2008 Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients - Clinical Chemistry and Laboratory Medicine 46 365-370.
62. Spina CS, Tangpricha V. Uskokovic M, Adorinic L, Maehr H & Holick MF 2006 Vitamin D and cancer. Anticancer Research 26 2515-2524.
63. Takayama S, Bimston DN, Matsuzawa S, Freeman BC, Aime-Sempe C, Xie Z, Morimoto, RI & Reed JC 1997 BAG-1 modulates the chaperone activity of Hsp70/Hsc7O. EMBO Journal 16 4887-4896.
64. Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS & Hewison M 2005 Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemopreverition and treatment. Journal of Steroid Biochemistry and Molecular Biology 97 103-109.
65. Trump DL, Muindi J, Fakih M, Yu WD & Johnson CS 2006 Vitarnin D compounds: clinical development as cancer therapy and prevention agents. Anticancer Research 26 2551-2556.
66. White P & Cooke N 2000 The multifunctional properties and characteristics of vitamin D-binding protein. Trends in Endocrinology and Metabolism 11 320-327.
67. Whitfield GK, Dang HT, Schluter SF, Bernstein RM, Bunag T, Manzon LA, Hsieh G, Dominguez CE, Youson JH, Haussler MR et al. 2003 Cloning of a functional vitamin D receptor from the lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth. Endocrinology 144 2704-2716.
68. Wicker T, Sabot F, Hua-Van A, Bennetzen JL, Capy P, Chalhoub B, Flavell A, Leroy P, Morgante M, Panaud O et al. 2007 A unified classification system for eukaryotic transposable elements. Nature Reviews. Cancer 8 973-982.
69. Wu S, Ren S, Chen H, Chun RF, Gacad Mh & Adams JS 2000 Intracellular vitamin D binding proteins: novel facilitators of vitamin D-directed transactivation. Molecular Endocrinology 14 1387-1397.
70. Wu S, Chun R, Gacad W, Ren S, Chen H & Adams JS 2002 Regulation of 1,25-dihydroxyvitamin D synthesis by intracellular vitamin D binding prorem-1. Endocrinology 143 4135.
71. Yamamoto N & Naraparaju VR 1996 Role ofvitarnin D3-binding protein in activation of mouse macrophages. Journal of Immunology 157 1744-1749.
72. Yamaoka K, Shindo, M, Iwasaki K, Yamaoka I, Yamamoto Y, Kitagawa H & Kato S 2007 Multiple co-activator complexes support ligand-incluced transactivation function of VDR, Archives of Biochemistry and Biophysics 460 166-171.
73. Yim S, Dhawan P, Ragunath C & Christakos S 2007 Diamond G Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxy-vitamin D (3). Journal of Cystic Fibrosis 6 403-410.
74. Zella LA, Shevde NK, Hollis BW, Cooke NE & Pike JW 2008 Vitamin D binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels ofthe hormone in vivo. Endocrinology (In press).